secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANGIODYNAMICS INC (ANGO)
CIK:        0001275187
Form:       8-K
Filed at:   2022-07-12T23:59:59+00:00
Accession:  0000914121-22-004052
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AngioDynamics Q4 sales $87M (+13% YoY), GAAP EPS -$0.16; FY23 rev guide $342-348M
--------------------------------------------------------------------------------

- Q4 net sales $87.0M (+13.2% YoY); Med Tech sales up 40% to $22.6M.
- GAAP loss per share $0.16; adjusted EPS $0.01; full-year GAAP loss $0.68.
- Full-year net sales $316.2M (+8.7% YoY); gross margin declined 150 bps to 52.4%.
- FY2023 guidance: net sales $342-348M, gross margin 52.5-54.5%, adjusted EPS $0.01-$0.06.
- Cash $28.8M at May 31; $25M drawn on revolver; operating cash flow $8.6M in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1275187/000091412122004052/0000914121-22-004052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1275187/000091412122004052/an58016818-8ki.htm
  HTML page:      https://secwatch.observer/filing/0000914121-22-004052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer